Spots Global Cancer Trial Database for Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
Official Title: Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
Study ID: NCT02090530
Conditions
Interventions
Study Description
Brief Summary: Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
Detailed Description: This study supports the collection of tumor specimens for CLIA-certified genomic testing and research testing in parallel. CLIA-certified tests have established measurements of accuracy and precision which allow for return of results. This study does not involve treatment, only testing, which could be used to meet eligibility criteria in other trials.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Ohio State University Wexner Medical Center, Columbus, Ohio, United States
Contact Details
Name: Sameek Roychowdhury, MD, PhD
Affiliation: Ohio State University Wexner Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
